NASA Resumes Cygnus XL Cargo Docking with Space Station After Software Fix 
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales 
US Quantum Stocks Surge After $2 Billion Government Investment 
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship 
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1 
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 
Taiwan Simulates Repelling Chinese Invasion in Major Coastal Live-Fire Exercise 
Meta Challenges Australia’s Proposed Tech Tax, Citing U.S. Trade Agreement Concerns 
Brazil Extends Fuel Subsidies and Tax Relief Measures Through July 2026 Amid Global Oil Market Volatility 
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions 
Armenia Election 2026: Early Results Show Ruling Civil Contract Party in Strong Lead 
Australia Sues 3M for Over A$2 Billion Over PFAS Firefighting Foam Contamination 
SoftBank Becomes Japan’s Most Valuable Company as AI-Fueled Rally Drives Shares to Record High 
Peru Election 2026: Sanchez Takes Narrow Lead Over Fujimori 
Alphabet Unveils $80 Billion Capital Raise to Accelerate AI Expansion, Secures $10 Billion Backing from Berkshire Hathaway 
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern 
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies 
U.S. President Donald Trump has signed an executive order aimed at expanding the use of artificial intelligence (AI) in pediatric cancer research. The order provides an additional $50 million in research grants to accelerate progress in finding cures for childhood cancers, according to White House officials.
This move builds on the National Cancer Institute’s (NCI) Childhood Cancer Data Initiative, a decade-long, $500 million program launched in 2019 to collect and share vital data on pediatric cancers. Michael Kratsios, director of the White House Office of Science and Technology Policy, highlighted that childhood cancer remains the leading cause of disease-related deaths among children in the United States, with cases rising more than 40% since 1975.
Kratsios noted that advances in AI can now be harnessed to sharpen diagnoses, improve clinical trials, fine-tune treatment strategies, and enhance prevention methods. Data gathered through the NCI initiative is expected to empower researchers with new tools to tackle the complexity and diversity of pediatric cancers.
In addition to the $50 million in grants, the National Institutes of Health (NIH) will double its commitment by investing another $50 million. This funding aims to attract leading scientific teams through competitive research opportunities. Further investments are also anticipated to strengthen ongoing initiatives.
The announcement comes despite Trump’s 2026 budget proposal, which suggested a 37% cut to the NCI budget. Lawmakers in both the House and Senate, however, have pushed back against these cuts, and budget negotiations remain ongoing.
Globally, the World Health Organization reports that around 400,000 children and adolescents are diagnosed with cancer each year. While advances in adult cancer research have surged with AI, pediatric cancer research has lagged due to challenges like cancer rarity, diversity, and ethical concerns over patient data protection.
By reinforcing funding and leveraging AI, the administration aims to close this gap and accelerate life-saving innovations in childhood cancer treatment.
